| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549351A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/06/2005 | EP1549319A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 07/06/2005 | EP1549301A2 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 07/06/2005 | EP1212049B1 Use of thiamphenicol for thetreatment of chlamydia pneumoniae infections |
| 07/06/2005 | EP1044001B1 Integrin receptor antagonists |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1635892A Ziprasidone composition and synthetic controls |
| 07/06/2005 | CN1635891A Tetrahydroquinoline analogues as muscarinic agonists |
| 07/06/2005 | CN1635882A Methods for treating hearing loss |
| 07/06/2005 | CN1635874A Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 07/06/2005 | CN1634610A Medical cornea paster and its preparation method |
| 07/06/2005 | CN1634529A Traditional Chinese medicine preparation for treating myopia and method for preparing the same |
| 07/06/2005 | CN1634528A Traditional Chinese medicine preparation for treating amblyopia and method for preparing the same |
| 07/06/2005 | CN1634516A Medicine composition for treating labyrinthine syndrome and its preparation method |
| 07/06/2005 | CN1634408A Preparation method and application of Chinese medicinal preparation for ophthalmology |
| 07/06/2005 | CN1634383A Chinese violet containing capsule and its preparing process |
| 07/06/2005 | CN1634371A Pterodontic preparation for treating infectious diseases and preparation method thereof |
| 07/06/2005 | CN1634358A Composition containing microbe and virus resistant natural essential oils and phospholipins |
| 07/06/2005 | CN1634321A Chinese traditional medicine preparation for treating diabetic chronic retinopathy and preparation method thereof |
| 07/06/2005 | CN1634272A Eye disease treating medicine and its preparing process |
| 07/06/2005 | CN1634195A Eye disease treating medicine |
| 07/06/2005 | CN1634149A Vision acuity improving eye drop and its preparation |
| 07/06/2005 | CN1634135A Drug for treating eye itch and eye conjunctivitis |
| 07/06/2005 | CN1634123A Eye formulation administering system containing lecithin and sodium hyaluronic acid and its preparing method |
| 07/06/2005 | CN1634118A Antivirus formulation containing polysaccharide polyanion zinc salt and its preparing process |
| 07/06/2005 | CN1634071A Gel agent for treating glaucoma and its preparing process |
| 07/06/2005 | CN1634070A Eye drop of pazufloxacin mesilate, its preparing method and application |
| 07/06/2005 | CN1634046A Use of rapamycin in preparation of intraocularly embedded drug |
| 07/06/2005 | CN1634015A Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
| 07/06/2005 | CN1209358C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/06/2005 | CN1209351C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR3 receptor antagonists |
| 07/06/2005 | CN1209119C Powder for treating eye disease and preparing method thereof |
| 07/06/2005 | CN1209117C Small pellet of extraction of kudzu vine, and its preparation method |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914070 Ophthalmic compositions for treating ocular hypertension |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 06/30/2005 | WO2005058932A1 Tear layer stabilizer |
| 06/30/2005 | WO2005058338A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | US20050143578 Compounds and methods |
| 06/30/2005 | US20050143468 administering amfenac or nepafenac; ophthalmic disorder, proliferative diabetic retinopathy, vision defects |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143393 Bactericides; infection therapy; topical administering |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050142128 Treatment for diseases of the eye inner ear and central nervous system |
| 06/30/2005 | US20050142072 Drug delivery into nose; controlling concentration into blood; using opioid or non-steroil antiinflammatory dryg |
| 06/30/2005 | CA2580663A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | CA2547195A1 Microemulsion preconcentrate comprising a renin inhibitor |
| 06/29/2005 | EP1548121A1 Novel physiologically active substances |
| 06/29/2005 | EP1548032A1 Kdr peptides and vaccines comprising the same |
| 06/29/2005 | EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same |
| 06/29/2005 | EP1547618A1 Drug for auditory dysfunction |
| 06/29/2005 | EP1547599A1 Transparent eye drops containing latanoprost |
| 06/29/2005 | EP1547597A2 Use of adatanserin for the treatment of neurodegenerative conditions |
| 06/29/2005 | EP1546451A1 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546130A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1546084A1 2,4-dihydroxybenzoic acid derivatives |
| 06/29/2005 | EP1545590A1 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |
| 06/29/2005 | EP1545589A1 A method of modulating endothelial cell activity |
| 06/29/2005 | EP1545572A2 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 06/29/2005 | EP1545555A2 Compositions and methods for treating epithelial and retinal tissue diseases |
| 06/29/2005 | EP1545551A1 Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
| 06/29/2005 | EP1545548A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545517A1 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma |
| 06/29/2005 | EP1545494A1 Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma |
| 06/29/2005 | EP1545412A1 Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues |
| 06/29/2005 | EP1545208A2 Methods of using beta glucan as a radioprotective agent |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP0862456B1 Hyaluronidase compositions for treating intravitreal hemorrhagic blood |
| 06/29/2005 | CN1633444A 6-11 bicyclic ketolide derivatives |
| 06/29/2005 | CN1633440A Derivatives of branched-chain lipophilic molecules and uses thereof |
| 06/29/2005 | CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633308A Treatment of ophthalmic disorders using urea and urea derivatives |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633292A Cotherapy with an oxazolidinone and a vitamin B |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1633285A 组合物 The composition |
| 06/29/2005 | CN1631427A Bacteria and virus resisting and inflammation eliminating eye drop and its preparing process |
| 06/29/2005 | CN1631398A Powder for treating red eye |
| 06/29/2005 | CN1631397A Decoction for cooling blood and dispersing heat |
| 06/29/2005 | CN1631396A Chinese medicine for treating acute or purulent otitis media and the preparation thereof |
| 06/29/2005 | CN1208323C Alpha-substituted carboxylic acid derivatives |